Hong, Qin
Chen, Tian
Han, Wenyu
Wang, Shuxia
Lian, Chaoyang
Zhang, Yujie
Ruan, Lizhu
Wang, Tingfeng
Lin, Cheng
Song, Congcong
Liu, Qingwei
Wang, Xiaoli
Cong, Yao
Huang, Zhong
Funding for this research was provided by:
National Key Research and Development Program of China (2024YFA1803102)
National Natural Science Foundation of China (32370991)
Article History
Received: 30 September 2025
Accepted: 6 February 2026
First Online: 24 February 2026
Competing interests
: W.H., C.L., L.R., Q.L., and X.W. are current employees of Huasong (Shanghai) Biomedical Technology Co., LTD. Q.L., X.W., L.R., T.C., and W.H. are inventors of a patent (CN 202410797193.1) on the 5C6 mAb owned by Huasong (Shanghai) Biomedical Technology Co., LTD. Q.L., X.W., L.R., C.Y.L., Z.H., and T.C. are listed as inventors in a pending patent application (CN 202511196350.4) on the 3G10 mAb filed by Huasong (Shanghai) Biomedical Technology Co., LTD. The other authors declare that they have no competing interests.